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heterocyclic systems, we have carried out the
reaction of mercaptoaminotriazole with 2-chloro-
3-formyl-6/8-substituted quinolines in both the
conditions, DMF and DMFIK2C03• It has been
found that the same. products, 2-chloro-6/8-substi-
tuted-3-(3-alkyllaryl-5, 6-dihydro'-s-triazolo[3,4-b]
[1,3,4]thiadiazol-6-yl)quinolines 3, are obtained
when the reaction is carried out in DMF or
DMFIK2C03•
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Various 3-substituted-4-amino-5-mercapto-l, 2, 4-tri-
azoles 2 when condensed with substituted 2-chloro-3-
formylquinolines 1 in DMF or DMFIK2C03 give 2-
chloro-6/8-substituted-3-(3-alkyllaryl-5, 6-dihydro-s-tri-
azolo[3,4-b][I, 3, 4]thiadiazol-6-yl)quinolines 3. The
quinolines 3 have been assessed for their antiinflamma-
tory, antibacterial and antifungal activities.
In recent years, the chemistry of quinolines'" and
their derivatives has gained increasing attention,
particularly because substituted quinolines are
associated with immense biological activities'",
Like-wise, a triazolo-thiadiazole system is also
found to be associated with wide range of
biological activities'<'". As a part of our
programme on the synthesis of potentially bio-
active heterocyclic systems'<", we report herein
the synthesis of 2-chloro-6/8-substituted-3-(3-
alkyl/aryl-5, 6-dihydro-s-triazolo[3,4-b][ 1,3,4]-thi-
adiazol-6-yl)quinolines 3 incorporating two bio-
logically active moieties in a single molecule. The
title compounds have been evaluated for their anti-
inflammatory, antibacterial and antifungal acti-
vities.
It has been reported" that the reaction of o-ami-
nothiophenol and 2-chloro-3-formyl-6-methylqui-
noline when carried out in DMF containing K2C03
proceeds with the displacement of chlorine atom
giving quino[2, 3-b ][1 ,5]benzothiazepines, while
in only DMF it gives 3-(benzothiazolin-2-yl)-2-
chloro-o-methylquinoline retaining the chlorine
atom. Mercaptoaminotriazole is analogous to 0-
aminothiophenol and based on our interest in
exploring the utility of mercaptoaminotriazole as
an important synthon in the synthesis of
Note
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The required synthons substituted 2-chloro-
3-formylquinolines 19 1, 3-substituted-4-amino-5-
mercapto-l, 2, 4-triazoles20,21 2 were prepared by
literature methods.
The structural assignments of 3 are based on IR
and IH NMR data. The IR spectra of 3a-z showed
sharp bands near 1620 and 3250-3375 ern" due to
C=N and NH groups respectively. TIle bands that
appeared at 3210, 3150 (NH2), 1130 ern"! (C=S)
and 1690 cm" (C=O) for the starting triazoles 2
and aldehydes 1 respectively were absent in the
newly formed compounds 3a-z. The IH NMR
spectra of 3a-z exhibited broad singlets at 84.9-
5.4, exchangeable with D20, due to -NH-CH
proton whereas, -NH-CH protons appeared as a
singlet at 8 ~.30-6.52. The aromatic protons
appeared as a multiplet at 87.20-8.40 and as a
singlet at 88.85-9.1. The IH NMR spectra of 3a-z
also showed the absence of a broad singlet of one-
proton intensity at 812.8-13.1 attributable to SH
proton of the starting mercaptoaminotriazoles 2.
Antiinflammatory activity. The compounds 3
were assessed for their antiinflammatory activity
by carrageenan-induced oedema in rat paw
following the technique of Winter et at". The test
compounds showed feeble to moderate activity
ranging from 2.14 to 35.53%, while significant
activity was observed in 3c, 3d, 3u, 3w and 3x
taking phenylbutazone as standard which showed
58% inhibition (cfTable J).
Antibacterial and antifungal activities. The
Table I---Characterisation data and antiinflammatory activity of 3a-z
Compd R R' R" m.p. Yield Mol. formula" Antiinflammatory
(OC) (%) Activity
(% inhibition)
3a CH2C6Hs OMe H 242-43 50 C2oH16CINsOS 4.19
3b 4-0MeC6H. OMe H 275-76 55 C2aH 16CINs02S 12.14
3c 2-MeC6H. OMe H 218-19 83 C2oH16CINPS 35.53
3d Me OMe H 207-08 80 C1.H12CINsOS 32.33
3e Et OMe H 214-15 75 C1sH1.CINsOS 23.07
3f n-Pr OMe H 183-84 83 C16H16CINsOS 12.78
3g C6HS Me H 257-58 58 C19H14CINsS 8.47
3h CH2C6Hs Me H 218-20 55 C2oH16CINsS 33.82
3i 4-0MeC6H. Me H 258-61 50 C20HI6CINsOS 14.28
3j 2-MeC6H. Me H 265-66 52 C20HI6CINsS 9.09
3k Me Me H 213-15 82 C1.H12CINsS 13.98
31 Et Me H 219-20 90 C1sH1.CINsS 2.14
3m n-Pr Me H 227-28 75 C16H16CINsS 20.97
3n C6HS H Me 222-23 74 CI9H1.CINsS 11.86
30 CH2C6Hs H Me 180 65 C20HI6CINsS 7.35
3p 4-0MeC6H. H Me 217 68 C2oH16CINsOS 9.55
3q 2-MeC6H. H Me 259-60 77 C2oH16CINsS 14.42
3r Me H Me 275 50 C1.H12CINsS 12.14
3s Et H Me 212-13 80 C1sH1.CINsS 14.70
3t n-Pr H Me 187 65 C16H16ClNsS 8.12
3u CH2C6Hs H H 216-17 50 CI9H1.ClNsS 24.28
3v 4-0MeC6H. H H 222-23 56 CI9H1.ClNPS 27.81
3w 2-MeC6H. H H 256-57 51 C19H14ClNsS 32.01
3x Me H H 251-52 73 C13HIOClNsS 28.0
3y Et H H 210-11 67 C1.HI2ClNsS 35.33
3z n-Pr H H 204-05 73 ClsH14CINsS 31.20
*All the compounds gave C, H and N analyses within ±0.4%.
antibacterial activity of the compounds 3a-z was
determined in vitro using paper disc method
against two pathogenic micro-organisms Escheri-
cia coli (Gram negative) and Staphylococcus
aureus (Gram-positive) at 200 ,ug/mL and 100,ug/
mL concentrations respectively, in the nutrient
agar media. Out of the compounds tested 3a, d, f,
g, m and r exhibited a low degree of inhibition
against S. aureus and E. coli.
Similarly, the antifungal screening of the
compounds 3a-z was carried out in vitro by paper
disc method against two fungi, Aspergillus niger
and Candida albicans and they did not show
significant antifungal activity.
Experimental Section
General. All melting points were taken on a
Buchi melting point apparatus and are uncorrected.
IR spectra (vrnax in cm') were recorded on a
Shimadzu-435 spectrophotometer using KBr disc
and IH NMR spectra (CDC13+DMSO-d6/TFA) on
Varian T-60A and EM-390 spectrometers (60 MHz
and 90 MHz) using TMS as internal standard
(chemical shifts in 6, ppm). Purity of the
compounds was checked by TLC on silica gel G
plates and spots were visualised by iodine vapours.
2-Chloro-6-methoxy-3-(3-benzyl-5,6-dibydro-
s-triazolo [3, 4-b][1, 3,4]thiadiazol-6-yl)quinoline
(3a): General procedure. An equimolar mixture
of 4-amino-3-benzyl-5-mercapto-s-triazole (1.03 g,
0.005 mole) and 2-ch10ro-3-formy1-6-methoxyqui-
noline (1.10 g, 0.005 mole) in DMF (30 ml.), was
stirred at 70-80°C for 12hr. On cooling, the solid-
separated was filtered, washed with DMF, water
and crystallized from DMF as white crystals; IR:
3370 (NH), 1628 (C=N), 1450 (C-N) , 1275
(C-O-C asymmetric), 1045 (C-O-C symmetric),
815 (C-Cl), 680 (C-S); IH NMR (CDC13+DMSO-
d6): 53.9 (s, 3H, -OCH3), 4.15 (s, 2H, Ar-CH2),
5.25 (bs, lH, NH), 6.38 (s, lH, CH), 7.20-8.80 (m,
8H, Ar-H), 8.96 (s, IH, ArC-4H).
Compounds 3b-z were prepared similarly and
their characterisation data are given in Table 1.
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